BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 31360646)

  • 1. Canine transmissible venereal tumor: First report of three clinical cases from Tripoli, Libya.
    Hiblu MA; Khabuli NM; Gaja AO
    Open Vet J; 2019 Jul; 9(2):103-105. PubMed ID: 31360646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vincristine and ivermectin combination chemotherapy in dogs with natural transmissible venereal tumor of different cyto-morphological patterns: A prospective outcome evaluation.
    Ferreira Bulhosa L; Estrela-Lima A; da Silva Solcà M; Diniz Gonçalves GS; Larangeira DF; de Pinho FA; Barrouin-Melo SM
    Anim Reprod Sci; 2020 May; 216():106358. PubMed ID: 32414469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Theriogenology question of the month. Transmissible venereal tumor (TVT).
    Hasler AH; Weber WT
    J Am Vet Med Assoc; 2000 May; 216(10):1557-9. PubMed ID: 10825939
    [No Abstract]   [Full Text] [Related]  

  • 4. Predictive factors for the regression of canine transmissible venereal tumor during vincristine therapy.
    Scarpelli KC; Valladão ML; Metze K
    Vet J; 2010 Mar; 183(3):362-3. PubMed ID: 19109042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Canine transmissible venereal tumour: a review.
    Ganguly B; Das U; Das AK
    Vet Comp Oncol; 2016 Mar; 14(1):1-12. PubMed ID: 23981098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination therapy using intratumoral bacillus Calmette-Guerin (BCG) and vincristine in dogs with transmissible venereal tumours: therapeutic efficacy and histological changes.
    Mukaratirwa S; Chitanga S; Chimatira T; Makuleke C; Sayi ST; Bhebhe E
    J S Afr Vet Assoc; 2009 Jun; 80(2):92-6. PubMed ID: 19831270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Canine transmissible venereal tumour: a morphological and immunohistochemical study of 11 tumours in growth phase and during regression after chemotherapy.
    Gonzalez CM; Griffey SM; Naydan DK; Flores E; Cepeda R; Cattaneo G; Madewell BR
    J Comp Pathol; 2000 May; 122(4):241-8. PubMed ID: 10805977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intratumoral recombinant human interferon alpha-2a and vincristine combination therapy in canine transmissible venereal tumour.
    Kanca H; Tez G; Bal K; Ozen D; Alcigir E; Atalay Vural S
    Vet Med Sci; 2018 Nov; 4(4):364-372. PubMed ID: 30117719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transmissible venereal tumor: a retrospective study of 29 cases.
    Rogers KS; Walker MA; Dillon HB
    J Am Anim Hosp Assoc; 1998; 34(6):463-70. PubMed ID: 9826280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does the tumour microenvironment alter tumorigenesis and clinical response in transmissible venereal tumour in dogs?
    Ballestero Fêo H; Montoya Flórez L; Yamatogi RS; Prado Duzanski A; Araújo JP; Oliveira RA; Rocha NS
    Vet Comp Oncol; 2018 Sep; 16(3):370-378. PubMed ID: 29508538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of ocular canine transmissible venereal tumor.
    Milo J; Snead E
    Can Vet J; 2014 Jan; 55(1):1245-9. PubMed ID: 24381345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transmission of canine transmissible venereal tumour between two dogs in the UK.
    Hayes AM; Schiavo L; Constantino-Casas F; Desmas I; Dobson J; Draper A; Elliot J; Genain MA; Wang J; Murchison EP
    J Small Anim Pract; 2023 Sep; 64(9):590-594. PubMed ID: 36990106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a genetic assay for canine transmissible venereal tumour diagnosis in Brazil.
    Castro KF; Strakova A; Tinucci-Costa M; Murchison EP
    Vet Comp Oncol; 2017 Jun; 15(2):615-618. PubMed ID: 27135875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of the multi-drug resistance 1, p53, b cell lymphoma 2, and bcl 2-associated X genes in the biologic behavior and chemotherapeutic resistance of canine transmissible venereal tumors.
    Alzate JM; Montoya-Florez LM; Pérez JE; Rocha NS; Pedraza-Ordonez FJ
    Vet Clin Pathol; 2019 Dec; 48(4):730-739. PubMed ID: 31777108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of vincristine treatment on semen quality in a dog with a transmissible venereal tumour.
    Gobello C; Corrada Y
    J Small Anim Pract; 2002 Sep; 43(9):416-7. PubMed ID: 12238508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary intranasal transmissible venereal tumour in the dog: a retrospective study of six spontaneous cases.
    Papazoglou LG; Koutinas AF; Plevraki AG; Tontis D
    J Vet Med A Physiol Pathol Clin Med; 2001 Sep; 48(7):391-400. PubMed ID: 11599677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-drug chemotherapy of canine transmissible venereal tumor with cyclophosphamide, methotrexate, or vincristine.
    Amber EI; Henderson RA
    J Vet Intern Med; 1992; 6(5):300. PubMed ID: 1432905
    [No Abstract]   [Full Text] [Related]  

  • 18. A Clinico-pathological study on the effect of vincristine on transmissible venereal tumour in dogs.
    Nak D; Nak Y; Cangul IT; Tuna B
    J Vet Med A Physiol Pathol Clin Med; 2005 Sep; 52(7):366-70. PubMed ID: 16109105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapeutic management of transmissible venereal tumors in 30 dogs.
    Brown NO; Calvert C; MacEwen EG
    J Am Vet Med Assoc; 1980 May; 176(10 Pt 1):983-6. PubMed ID: 7380719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vincristine for treatment of transmissible venereal tumor in the dog--.
    Calvert CA; Leifer CE; MacEwen EG
    J Am Vet Med Assoc; 1982 Jul; 181(2):163-4. PubMed ID: 6749780
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.